Ying Chen

8.8k total citations · 2 hit papers
239 papers, 6.2k citations indexed

About

Ying Chen is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Ying Chen has authored 239 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Molecular Biology, 61 papers in Oncology and 38 papers in Immunology. Recurrent topics in Ying Chen's work include Acute Myeloid Leukemia Research (19 papers), Inflammasome and immune disorders (14 papers) and Immune Cell Function and Interaction (14 papers). Ying Chen is often cited by papers focused on Acute Myeloid Leukemia Research (19 papers), Inflammasome and immune disorders (14 papers) and Immune Cell Function and Interaction (14 papers). Ying Chen collaborates with scholars based in China, United States and Japan. Ying Chen's co-authors include John W. Lyga, Yang Yang, Kathleen M. Giacomini, Zuwei Li, Jian‐xing Ma, Sagar Agarwal, William F. Elmquist, Naveed Shaik, Shuzhong Zhang and Nicole T. Ranger and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Ying Chen

216 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The NLRP3 inflammasome: contributions to inflammation-related diseases

2023 200 citations Ying Chen, Yang Yang et al. profile →
Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases

2024 141 citations Qian Lu, Ying Chen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ying Chen China	38	2.5k	1.7k	1.1k	760	463	239	6.2k
Yong‐Yeon Cho South Korea	54	5.1k 2.0×	1.5k 0.8×	830 0.8×	573 0.8×	1.0k 2.2×	268	8.6k
Ling Li China	45	3.7k 1.5×	1.1k 0.6×	1.0k 1.0×	515 0.7×	1.1k 2.3×	304	7.0k
Ying Huang United States	45	4.6k 1.8×	1.5k 0.9×	645 0.6×	742 1.0×	1.1k 2.5×	195	8.3k
Guo Wei United States	18	4.1k 1.6×	774 0.4×	481 0.4×	542 0.7×	647 1.4×	40	6.2k
Jakob Troppmair Austria	50	4.4k 1.8×	1.0k 0.6×	973 0.9×	327 0.4×	705 1.5×	157	7.9k
Li Tan China	37	2.6k 1.0×	892 0.5×	541 0.5×	357 0.5×	370 0.8×	233	5.0k
Wei Zhang China	44	3.1k 1.2×	1.3k 0.7×	594 0.6×	496 0.7×	1.4k 3.0×	351	7.0k
Kari Pulkki Finland	47	2.0k 0.8×	886 0.5×	742 0.7×	491 0.6×	424 0.9×	206	8.0k
Aldo Pinto Italy	39	1.7k 0.7×	802 0.5×	1.1k 1.0×	396 0.5×	245 0.5×	109	4.3k
Jun Wang China	40	2.2k 0.9×	1.2k 0.7×	554 0.5×	841 1.1×	1.1k 2.4×	269	6.3k

Countries citing papers authored by Ying Chen

Since Specialization

Citations

This map shows the geographic impact of Ying Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Chen more than expected).

Fields of papers citing papers by Ying Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Chen. The network helps show where Ying Chen may publish in the future.

Co-authorship network of co-authors of Ying Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Chen. A scholar is included among the top collaborators of Ying Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Chen. Ying Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Ying, Ou Xu, Yibin Liu, et al.. (2025). Feedback-Amplified Drug Delivery of αPD-L1-Modified Lipoplatin for Chronological Synergy in NSCLC through PD-L1 Upregulation. ACS Applied Materials & Interfaces. 17(40). 55861–55875.

Chen, Ying, et al.. (2025). Relationship prediction between clinical subtypes and prognosis of critically ill patients with cirrhosis based on unsupervised learning methods: A study from two critical care databases. International Journal of Medical Informatics. 201. 105952–105952.

Özcan, Muhıt, Ryan D. Cassaday, Ewa Zarzycka, et al.. (2025). Efficacy and safety of currently approved and lower starting doses of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukemia: a phase IV study. Haematologica. 110(8). 1736–1746. 1 indexed citations

Wang, Jin‐Yuan, Jingru Jiang, Jie Jiang, et al.. (2025). Patient-reported outcomes of rimegepant for acute and preventive treatment of migraine in China: a prospective, multicenter, real-world study. The Journal of Headache and Pain. 26(1). 242–242.

Liang, Tu-Liang, Hudan Pan, Peiyu Yan, et al.. (2024). Serum taurine affects lung cancer progression by regulating tumor immune escape mediated by the immune microenvironment. Journal of Advanced Research. 73. 427–442. 7 indexed citations

Chen, Ying, et al.. (2024). Research on work-stress recognition for deep ground miners based on depth-separable convolutional neural network. Journal of Loss Prevention in the Process Industries. 91. 105410–105410. 2 indexed citations

Chen, Ying, et al.. (2024). Research on the effects of operational fatigue and bagging-SVM recognition of deep coal mine workers. Journal of Loss Prevention in the Process Industries. 94. 105508–105508. 3 indexed citations

Lin, Xiaotong, Xin Dong, Kunyuan Wang, et al.. (2024). Radiotherapy enhances the anti-tumor effect of CAR-NK cells for hepatocellular carcinoma. Journal of Translational Medicine. 22(1). 929–929. 16 indexed citations

Zhang, Jing, Yang Zhang, Li Liu, et al.. (2024). Analysis of mechanism, therapeutic strategies, and potential natural compounds against atherosclerosis by targeting iron overload-induced oxidative stress. Biomedicine & Pharmacotherapy. 177. 117112–117112. 6 indexed citations

10.

Huang, Hanji, Mingjun Zheng, Xiong Qin, et al.. (2023). Hsa_circ_0007031 promotes the proliferation and migration of osteosarcoma cells by sponging miR-196a-5p to regulate the HOXB6. Biochemical Pharmacology. 214. 115667–115667. 8 indexed citations

11.

Chen, Ying, Ze Tao, Fan Zhang, et al.. (2023). Analysis of Edwardsiella piscicida induced transcriptome profiles in macrophages of black rockfish (Sebastes schlegelii) provides insights into the trigger of pyroptosis. Aquaculture. 577. 739967–739967. 3 indexed citations

12.

Zhao, Huadong, Ying Chen, Qian Lu, et al.. (2023). Lycorine protects against septic myocardial injury by activating AMPK-related pathways. Free Radical Biology and Medicine. 197. 1–14. 12 indexed citations

13.

Shen, Yingying, Qi Liu, Wenbin Liu, et al.. (2023). Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrospective study. Annals of Hematology. 102(3). 503–517. 1 indexed citations

14.

Huang, Liming, Ying Chen, Jiazheng Liu, et al.. (2023). Highly efficient and simultaneous production of thirteen taxanes from Taxus × media and mining of their new bioactivity. Process Biochemistry. 131. 175–187. 1 indexed citations

15.

Zhang, Deyu, et al.. (2023). Cytosine–phosphate–guanine oligodeoxynucleotides alleviate radiation-induced kidney injury in cervical cancer by inhibiting DNA damage and oxidative stress through blockade of PARP1/XRCC1 axis. Journal of Translational Medicine. 21(1). 679–679. 4 indexed citations

16.

Chen, Ying, et al.. (2023). Monitoring and detecting coal miners' fatigue status using MPA-LSSVM in the vision of smart mine. Process Safety and Environmental Protection. 179. 774–783. 9 indexed citations

17.

Segal, Neil H., Aiwu Ruth He, Toshihiko Doi, et al.. (2018). Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced Cancer. Clinical Cancer Research. 24(8). 1816–1823. 181 indexed citations

18.

Tolcher, Anthony W., Mario Sznol, Siwen Hu‐Lieskovan, et al.. (2017). Phase Ib Study of Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Combination with Pembrolizumab (MK-3475) in Patients with Advanced Solid Tumors. Clinical Cancer Research. 23(18). 5349–5357. 183 indexed citations

19.

Yi, Tangsheng, Ying Chen, Lin Wang, et al.. (2009). Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease. Blood. 114(14). 3101–3112. 222 indexed citations

20.

Zhang, Shuzhong, Katherine S. Lovejoy, James E. Shima, et al.. (2006). Organic Cation Transporters Are Determinants of Oxaliplatin Cytotoxicity. Cancer Research. 66(17). 8847–8857. 340 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact